PT - JOURNAL ARTICLE AU - Pons, Ariel AU - Whalley, Gillian AU - Jenkinson, Crispin AU - Morley, David AU - Coffey, Sean TI - Protocol for Generation of a Patient-Reported Outcome Measure of Quality of Life in Heart Valve Disease: The VALVQ AID - 10.1101/2023.05.20.23290285 DP - 2023 Jan 01 TA - medRxiv PG - 2023.05.20.23290285 4099 - http://medrxiv.org/content/early/2023/05/21/2023.05.20.23290285.short 4100 - http://medrxiv.org/content/early/2023/05/21/2023.05.20.23290285.full AB - Background There is an increasing prevalence of people worldwide with heart valve diseases (HVD), especially rheumatic heart disease, aortic stenosis, and mitral regurgitation, as well as people with a previous valve repair or replacement. Treatment decisions for HVD can be complex, making quality of life an important factor, but no questionnaire to measure quality of life across the lifespan of HVD exists. In this article, we describe the protocol for the development of such a questionnaire.Methods and Results The project will occur over four phases. First, people with HVD, family members and clinical experts will be interviewed to generate a list of questions (‘items’) that comprehensively describe participants’ quality of life. In the second phase, this will be formatted into a questionnaire that is pilot tested for functionality. In the third phase, items will be selected according to item distributions, factor analysis and rotation, and item response theory using the Graded Response Model to generate a final questionnaire containing only the best-performing items, which will then be tested for validity.Validity assessments will be repeated after final questionnaire administration in a new sample in the fourth phase.Conclusion The article gives a template for development of a patient report outcome measure (PROM) in the health sciences. It is expected that the final questionnaire, called the VALVQ, will allow clinical trials to more sensitively assess quality of life changes across the spectrum and lifespan in HVD.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was funded by the Department of Medicine, University of Otago.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Health and Disabilities Ethics Committee of Manatu Hauora: Ministry of Health, New Zealand Government, gave ethical approval for this work. (Approval number 19/NTA/163).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors